A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
about
The Role of Monocytes in Ischemic Stroke Pathobiology: New Avenues to ExploreThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.Specific depletion of Ly6C(hi) inflammatory monocytes prevents immunopathology in experimental cerebral malariaElucidation of monocyte/macrophage dynamics and function by intravital imaging.Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial CellsRole of CCR2 in inflammatory conditions of the central nervous system.PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease.Neurodegeneration severity can be predicted from early microglia alterations monitored in vivo in a mouse model of chronic glaucoma.Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse modelQuantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands.Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.Both Cerebral and Hematopoietic Deficiencies in CCR2 Result in Uncontrolled Herpes Simplex Virus Infection of the Central Nervous System in Mice.MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease.Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior.Migration of blood cells to β-amyloid plaques in Alzheimer's disease.The dynamics of monocytes and microglia in Alzheimer's disease.The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects.Central nervous system myeloid cells as drug targets: current status and translational challenges.Angry macrophages patrol for fibrin.The blood-brain barrier in Alzheimer's disease.Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.TREM2 enables amyloid β clearance by microglia.High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice.Intracerebral GM-CSF contributes to transendothelial monocyte migration in APP/PS1 Alzheimer's disease miceHepcidin attenuates amyloid beta-induced inflammatory and pro-oxidant responses in astrocytes and microglia.Can immunotherapy treat neurodegeneration?Complex role of chemokine mediators in animal models of Alzheimer's Disease.Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease
P2860
Q26768599-74189417-1822-49A5-BF1D-847BE36966B4Q26861263-17F3C0F6-031A-47DA-9B12-23053448D86FQ27303708-517F03EF-8ACD-4AE8-9E35-D8D6961580D1Q27309244-E8485EA3-BFFF-44CD-98BA-1FC058864C2CQ27313900-508E387A-B696-4302-98FF-511A315A56AAQ28072250-7242C994-DA5E-48FE-B1A3-5069D53B3576Q34153471-106A815B-C031-48E2-8DED-F10996C9485AQ34509539-3F33729C-0CC4-49D6-9723-95E250F919AAQ35558052-8F065E20-18F2-4D7F-B4D3-C7A701F39B38Q35592052-8BAD0262-3953-47ED-B8B9-5ECA99FCB7B8Q35607694-8DD9A16E-369F-4C54-9158-CD220D176386Q35804607-E724AE8E-8DC6-4E68-9CDE-ABB530636C5EQ36216207-87A2349D-F4AE-433B-A405-3821ECF9B7AAQ36934159-F1FFA0CD-A12E-4FC8-B760-1050BFD049D1Q37392519-2425CE5E-B0BE-4370-B0C1-1E13DD61F296Q37651394-6EF3F917-96D5-4583-A229-16B179B99ED1Q37739229-BFCA38DA-570F-4C13-A0BD-76D0D9081605Q38370756-33794780-52EA-4D77-A6B7-E408642B3212Q38423147-21CBD7B4-18D2-4C42-B8E2-0C2B2190359EQ38562255-D20CB0AA-3F33-494D-91AA-F6F436B7029DQ38658658-C674810B-296B-45F4-9870-C237A8A698F4Q38776043-2B93DDBB-1455-4926-A68A-B0337341659FQ38899745-AF2FA264-FA18-49CD-A66D-7C8D6E566F73Q39135845-07CEF839-E783-4F6E-A6B5-A16E6962CE5AQ40383488-271ACEDD-C0FF-4942-B18A-7579420C98CCQ42123847-F05DAAA9-C58A-447E-BF7A-B0603C58B968Q42732184-F733D8F6-BA14-47EA-A7E7-E9C6247F391BQ46837962-074E177F-1A98-47CF-80D8-0AD8242D27CDQ48186608-46EAA57C-BE79-40F6-A61E-06366FFD1947Q52315330-1F4AF7EE-464D-481C-9B44-69DD7B410B9DQ55380454-8CB94357-F3C6-4293-9748-60F57336749FQ57267899-29707A0A-C5B1-4D17-A39D-874A763E62E2
P2860
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@ast
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@en
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@nl
type
label
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@ast
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@en
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@nl
prefLabel
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@ast
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@en
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@nl
P2860
P3181
P356
P1476
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
@en
P2093
P2860
P304
P3181
P356
10.1093/JMCB/MJT028
P407
P577
2013-10-01T00:00:00Z